Clinical features of paraganglioma syndromes

Skull Base

Volumn 19, Issue 1, 2009, Pages 17-25

  Boedeker, Carsten Christof ^a,b   Neumann, Hartmut P H ^a   Offergeld, Christian ^a   Maier, Wolfgang ^a   Falcioni, Maurizio ^c   Berlis, Ansgar ^b   Schipper, Joerg ^d  

^a Department of Otorhinolaryngology Head and Neck Surgery ^*  (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c GRUPPO OTOLOGICO   (Italy)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

C; D; Neuroendocrine tumors; Paraganglioma; Paraganglioma syndromes; Pheochromocytoma; Succinate dehydrogenase subunits B

Indexed keywords

ABDOMINAL TUMOR; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; GENETIC SCREENING; HEAD AND NECK TUMOR; HUMAN; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REGISTER; THORAX TUMOR;

EID: 59449103665     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-0028-1103123     Document Type: Article

References (36)

1. Boedeker CC, Neumann HPH, Ridder GJ, Maier W, Schipper J. Paragangliomas in patients with mutations of the SDHD gene. Otolaryngol Head Neck Surg 2005; 132:467-470
2. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466
3. Neumann HPH, Pawlu C, Peczkowska M, et al. Distinct clinical features characterize paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951
4. Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005;294:2057-2063
5. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990;102:382-390
6. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer 2005;4:55-59
7. Chase WH. Familial and bilateral tumors of the carotid body. J Pathol Bacteriol 1933;36:1-12
8. Gimm O, Armanios M, Dziema H, Neumann HPH, Eng C. Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in non-familial pheochro-ocytomas. Cancer Res 2000;60:6822-6825
9. Neumann HPH, Berger DP, Siegmund G, et al. Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med 1993;329:1531-1538
10. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627
11. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996;276:1575-1579
12. Yip L, Lee JR, Shapiro SE, et al. Surgical management of hereditary pheochromocytoma. J Am Coll Surg 2004;198:525-535
13. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851
14. Niemann S, Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-270
15. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54
16. Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002;39:178-183
17. Astuti D, Douglas F, Lennard TW, et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001;357:1181-1182
18. Niemann S, Müller U, Engelhardt D, Lohse P. Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet 2003;113:92-94
19. Bauters C, Vantyghem MC, Leteutre E, et al. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes [letter]. J Med Genet 2003;40:E75
20. Baysal BE, Willett-Brozick JE, Andrade Filho PA, et al. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004;41:703-709
21. Peczkowska M, Cascon A, Prejbisz A, et al. Extra-adrenal and adrenal pheochromocytomas associated with a germ-line SDHC mutation. Nat Clin Pract Endocrinol Metab 2008;4:111-115
22. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003;63:5615-5621
23. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617-622
24. Birch-Machin MA, Taylor RW, Cochran B, Ackrell BA, Turnbull DM. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol 2000;48:330-335
25. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-737
26. Persky MS, Setton A, Niimi Y, Hartman J, Frank D, Berenstein A. Combined endovascular and surgical treatment of head and neck paragangliomas: a team approach. Head Neck 2002;24:423-431
27. Robbins KT, Clayman G, Levine PAet alAmerican Head and Neck Society. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-758
28. Vanharanta S, Buchta M, McWhinney SR, et al. Early onset renal cell carcinoma as novel extraparaganglial component of SDHB-associated hereditable paraganglioma. Am J Hum Genet 2004;74:153-159
29. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689-694
30. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005;4:61-68
31. Baysal BE. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab 2003;14:453-459
32. Hensen EF, Jordanova ES, van Minderhout IJ, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004;23:4076-4083
33. Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB. The role of genetics in the surgical management of familial endocrinopathy syndromes. J Am Coll Surg 2003;197:818-831
34. Timmers HJ, Pacak K, Bertherat J, et al. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clin Endocrinol (Oxf) 2008;68:561-566
35. Papaspyrou K, Rossmann H, Fottner C, et al. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene: a case report. Head Neck 2008;30:964-969
36. Boedeker CC, Neumann HPH, Bausch B, Maier W, Schipper J, Ridder GJ. Malignant paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 2007;137:126-129